Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Nucleic acids research - 11 Jul 1992

Ronen D, Teitz Y, Goldfinger N, Rotter V

Abstract excerpt

To facilitate the purification of wild type p53 protein, we established a recombinant p53 vaccinia viral expression system. Using this efficient eukaryotic expression vector, we found that the expressed p53 proteins retained their specific structural characteristics. A comparison between wild type and mutant p53 proteins showed the conservation of the typical subcellular localization and the expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral, Tumor
Share to Cloning, Molecular
Share to Fluorescent Antibody Technique

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HeLa Cells

Share to Mutation

Share to Recombinant Proteins

Share to Tumor Suppressor Protein p53

Share to Vaccinia virus

Source

Open in PubMed Open full text

Identifiers

PMID: 1630914
DOI: 10.1093/nar/20.13.3435
PMCID: PMC312500

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.PMID 1630914Read ↗

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.Semantic proximity Read ↗

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancerSemantic proximity Read ↗

p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1Semantic proximity Read ↗

Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection.Semantic proximity Read ↗

Expression of the catalytic subunit of human DNA polymerase delta in mammalian cells using a vaccinia virus vector system.Semantic proximity Read ↗

Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replicationSemantic proximity Read ↗

The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53.Semantic proximity Read ↗

Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein.Semantic proximity Read ↗

Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.Semantic proximity Read ↗

Detection of a protein encoded by the vaccinia virus C7L open reading frame and study of its effect on virus multiplication in different cell lines.Semantic proximity Read ↗

Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: catalytic site mutations reduce virulence but not virus replication in cultured cells.Semantic proximity Read ↗

Single-chain antibody against the common epitope of mutant p53: isolation and intracytosolic expression in mammalian cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.